Goldman Sachs
BMRA icon

Goldman Sachs’s Biomerica BMRA Stock Holding History

Goldman Sachs’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,112
Closed -$18K – 5826
2024
Q2 		$18K Buy
+5,112
New +$26K ﹤0.01% 5518
2021
Q1 		– Sell
-2,478
Closed -$99K – 6088
2020
Q4 		$99K Buy
2,478
+1,160
+88% +$58.1K ﹤0.01% 5291
2020
Q3 		$73K Sell
1,318
-1
-0.1% -$65 ﹤0.01% 5132
2020
Q2 		$77K Buy
1,319
+1
+0.1% +$56 ﹤0.01% 5026
2020
Q1 		$75K Buy
+1,318
New +$40.2K ﹤0.01% 4987

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs's BMRA Position: Q3 2024 in Review

Goldman Sachs sold out of Biomerica (BMRA) in Q3 2024, closing a stake of 5,112 shares — an estimated $18K sold.

Goldman Sachs first reported a position in BMRA in Q1 2020 and held it in 5 quarters. The position peaked at $99K in Q4 2020. 25 funds tracked by Wall St. Rank hold BMRA as of Q3 2024.

  • Goldman Sachs reported no remaining Biomerica position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 5,112 Biomerica shares in Q3 2024, an estimated $18K.
  • Goldman Sachs first reported a position in Biomerica in Q1 2020 and held it in 5 quarters.
  • Goldman Sachs's Biomerica position peaked at $99K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Biomerica as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.